Filana Therapeutics, Inc. Share Price

Filana Therapeutics, Inc. Share Price

NASDAQ: FLNA | Micro Cap
$0.44
-$0.05 (-9.78%) Last updated on 13 Nov, 2026 | 02:28 IST
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Filana Therapeutics, Inc. Stock Performance

Open
$0.46
Prev. Close
$0.49
Circuit Range
N/A
Day Range
$0.44 - $0.46
Year Range
$0.43 - $2.25
Volume
2,242
Average Traded
$0.44

Filana Therapeutics, Inc. Share Price Today

As of 13 November 2026, Filana Therapeutics, Inc.'s share price is $0.44. The stock opened at $0.46, compared to its previous close of $0.49. During today's trading session, Filana Therapeutics, Inc.'s share price traded between $0.44 and $0.46, with an average price of $0.45. Over the past 52 weeks, the stock has recorded a high of $2.25 and a low of $0.43. In terms of performance, Filana Therapeutics, Inc.'s share price has declined by 71.24% over the last six months and is down 74.04% on a year-on-year basis.

Filana Therapeutics, Inc. Share Price Chart

Line chart of the Filana Therapeutics, Inc. price trend over the selected period. The price fell overall, ranging from 0.44 to 0.47, ending at 0.44.
$0.44$0.46
L
Show Current Price
H

Filana Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap
$21.26M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-0.84
Revenue (TTM)
N/A
Return On Equity (TTM)
-72.79%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
N/A

Filana Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

ParticularsMar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00
Net Profit-$10.33-$8.60-$10.73
Net Profit MarginN/AN/AN/A
Income ChangeN/A16.75%-24.77%

About Filana Therapeutics, Inc.

Filana Therapeutics Inc is a biotechnology company focused on developing novel, investigational therapies to modulate the filamin A protein for the treatment of central nervous system disorders, such as tuberous sclerosis complex (TSC)-related epilepsy, and other diseases associated with dysregulation or overexpression of filamin A. Its therapeutic product candidate, simufilam, is a proprietary small molecule oral treatment drug being studied for the treatment of TSC-related epilepsy.

Filana Therapeutics, Inc. Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$0.61
$0.44
-29.42%
Oct 2026
$0.99
$0.62
-28.18%
Sep 2026
$0.88
$0.87
-7.08%
Aug 2026
$1.01
$0.93
-7.72%
Jul 2026
$1.21
$1.01
-15.48%
Jun 2026
$1.52
$1.20
-21.90%
May 2026
$1.47
$1.53
+4.79%
Apr 2026
$1.73
$1.46
-13.86%
Mar 2026
$2.25
$1.70
N/A

FLNA Share Price FAQs